Webb24 aug. 2024 · Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s and Parkinson’s disease, the Seattle... WebbSEATTLE, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), the RNA technology company advancing programmable medicine, today announced that Fierce Biotech has named it as one of 2024’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry. Sep …
Avantika Singh - Associate Scientist - Shape Therapeutics Inc ...
Webb9 nov. 2024 · Shape Therapeutics is a development-stage biotechnology company. It focuses on RNA-editing gene therapy. Its gene therapy platforms enable the … Webb16 juli 2024 · Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA editing technologies are spun... exurbs of los angeles
Krzysztof Potempa on Twitter: "Finally, there
WebbShape Therapeutics is headquartered in Seattle, Washington with a satellite site in Boston, Massachusetts. Current Job Openings Department All Departments CMC Finance & … Webb15 juli 2024 · SEATTLE, July 15, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics. (Shape TX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and … WebbShape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, … doddington sittingbourne